Carboplatin/Durvalumab/Gemcitabine/Tremelimumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, durvalumab, gemcitabine and tremelimumab that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Carboplatin-Durvalumab-Gemcitabine-Tremelimumab - Carboplatin/Durvalumab/Gemcitabine/Tremelimumab - Carboplatin/Durvalumab/Gemcitabine/Tremelimumab-actl - Carboplatin/Imjudo/Gemcitabine/Imfinzi - Imjudo/Imfinzi Plus Carboplatin/Gemcitabine - Tremelimumab/Durvalumab/Gemcitabine/Carboplatin